Viatris Inc. (VTRS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Company Overview - Viatris operates as three distinct businesses: a global generics company, an established brands company with iconic brands, and an emerging innovative brands platform [3] Financial Performance - In the last 12 months, Viatris generated $14.1 billion in revenue, $4.1 billion in EBITDA, and $2.2 billion in adjusted EBITDA [4] - The company reported $2.2 billion in free cash flow and $2.32 billion in adjusted EBITDA [4] Global Reach - Viatris operates in 165 countries and offers 1,400 unique products [4] - The company provides medicine to over 1 billion people annually, highlighting its significant impact on global health [4]